6-5369076-A-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_006567.5(FARS2):​c.506A>T​(p.Asp169Val) variant causes a missense change. The variant allele was found at a frequency of 0.00025 in 1,613,932 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 0 hom. )

Consequence

FARS2
NM_006567.5 missense

Scores

2
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 7.13

Publications

1 publications found
Variant links:
Genes affected
FARS2 (HGNC:21062): (phenylalanyl-tRNA synthetase 2, mitochondrial) This gene encodes a protein that transfers phenylalanine to its cognate tRNA. This protein localizes to the mitochondrion and plays a role in mitochondrial protein translation. Mutations in this gene can cause combined oxidative phosphorylation deficiency 14 (Alpers encephalopathy). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
FARS2 Gene-Disease associations (from GenCC):
  • metabolic disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • combined oxidative phosphorylation defect type 14
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 77
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leigh syndrome
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036999524).
BP6
Variant 6-5369076-A-T is Benign according to our data. Variant chr6-5369076-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 214338.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0013 (198/152154) while in subpopulation AFR AF = 0.0046 (191/41494). AF 95% confidence interval is 0.00407. There are 0 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FARS2NM_006567.5 linkc.506A>T p.Asp169Val missense_variant Exon 2 of 7 ENST00000274680.9 NP_006558.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FARS2ENST00000274680.9 linkc.506A>T p.Asp169Val missense_variant Exon 2 of 7 1 NM_006567.5 ENSP00000274680.4
FARS2ENST00000324331.10 linkc.506A>T p.Asp169Val missense_variant Exon 2 of 7 1 ENSP00000316335.5
FARS2ENST00000648580.1 linkn.506A>T non_coding_transcript_exon_variant Exon 2 of 9 ENSP00000497889.1

Frequencies

GnomAD3 genomes
AF:
0.00130
AC:
198
AN:
152036
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00462
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000279
AC:
70
AN:
251172
AF XY:
0.000177
show subpopulations
Gnomad AFR exome
AF:
0.00382
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000141
AC:
206
AN:
1461778
Hom.:
0
Cov.:
32
AF XY:
0.000106
AC XY:
77
AN XY:
727196
show subpopulations
African (AFR)
AF:
0.00520
AC:
174
AN:
33480
American (AMR)
AF:
0.000134
AC:
6
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53318
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1111998
Other (OTH)
AF:
0.000215
AC:
13
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00130
AC:
198
AN:
152154
Hom.:
0
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00460
AC:
191
AN:
41494
American (AMR)
AF:
0.000327
AC:
5
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67982
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000498
Hom.:
0
Bravo
AF:
0.00141
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000296
AC:
36
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Combined oxidative phosphorylation defect type 14 Uncertain:2Benign:1
Sep 06, 2022
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 13, 2018
Wong Mito Lab, Molecular and Human Genetics, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 20, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported as a variant of uncertain significance in siblings with juvenile idiopathic arthritis; these siblings were also homozygous for a variant in another gene that the authors classified as pathogenic (Rabinot et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30872671) -

Jun 06, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FARS2-related disorder Benign:1
Apr 29, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
T;T
Eigen
Uncertain
0.59
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
.;D
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L;L
PhyloP100
7.1
PrimateAI
Benign
0.42
T
PROVEAN
Pathogenic
-7.9
D;D
REVEL
Uncertain
0.29
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
0.99
D;D
Vest4
0.71
MVP
0.64
MPC
0.76
ClinPred
0.16
T
GERP RS
5.7
Varity_R
0.85
gMVP
0.80
Mutation Taster
=27/73
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146356199; hg19: chr6-5369309; API